ADINA CATALOGUE
Shop the
complete catalogue.
Search by product name or browse by category. Price, availability and the most important distinction stay visible throughout.
Showing all 18 results
-
Early human evidence
Acetyl Tetrapeptide-3
£37.0010 mgBatch file pendingScalp/follicle matrix focus distinguishes it from SNAP-8’s expression-line mechanism and GHK-Cu’s copper biology.
UnavailableAsk about availability -
Clinical research
ARA-290 (Cibinetide)
£72.0010 mgBatch file pendingSeparates tissue-protective EPO signalling from red-blood-cell production.
UnavailableAsk about availability -
Experimental
Dihexa
£66.0010 mgBatch file pendingHGF/c-Met synaptogenesis hypothesis, unlike Semax’s neurotrophic ACTH-fragment lineage.
UnavailableAsk about availability -
Preclinical
Epithalon
£58.0010 mgBatch file pendingA proposed pineal-derived bioregulator with telomere-focused claims, not a mitochondrial-targeting peptide.
UnavailableAsk about availability -
Preclinical
FOXO4-DRI
£92.0010 mgBatch file pendingA targeted experimental senolytic mechanism, not a mitochondrial support or endocrine peptide.
UnavailableAsk about availability -
Preclinical
Humanin
£68.0010 mgBatch file pendingPrimarily cytoprotective/anti-apoptotic, whereas MOTS-c centres on metabolic stress signalling.
UnavailableAsk about availability -
Preclinical
KPV
Price range: £27.47 through £29.9910 mgBatch file pendingA minimal anti-inflammatory alpha-MSH fragment rather than an antimicrobial peptide such as LL-37.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Established
Oxytocin
£42.0010 mgBatch file pendingA licensed endogenous hormone with direct smooth-muscle effects, not a kisspeptin/GnRH-axis activator.
UnavailableAsk about availability -
Experimental
P21
£58.0010 mgBatch file pendingA CNTF-lineage neurotrophic research material whose exact sequence must be verified before meaningful comparison.
UnavailableAsk about availability -
Early human evidence
Pal-GHK
£38.0010 mgBatch file pendingPalmitoylation—not copper binding—is the defining modification.
UnavailableAsk about availability -
Established
PT-141 (Bremelanotide)
£24.9910 mgBatch file pendingA centrally acting melanocortin agonist, mechanistically separate from reproductive-axis peptides such as kisspeptin.
Available · 20 in stockAdd to basket -
Early human evidence
Selank
Price range: £34.99 through £52.9910 mgBatch file pendingTuftsin-derived and primarily anxiolytic/neuroimmune in focus, unlike the ACTH-derived Semax.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Early human evidence
Semax
Price range: £24.99 through £42.9910 mgBatch file pendingACTH-fragment lineage and neuroprotection focus distinguish it from Selank’s tuftsin/anxiety profile.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Early human evidence
SNAP-8
£35.0010 mgBatch file pendingA topical neurotransmitter-release-mimetic cosmetic peptide rather than a matrix-remodelling peptide.
UnavailableAsk about availability -
Clinical research
SS-31 (Elamipretide)
£29.9910 mgBatch file pendingDirectly targets mitochondrial membrane cardiolipin, unlike MOTS-c’s signalling-peptide role.
UnavailableAsk about availability -
Established
Thymosin Alpha-1
£69.0010 mgBatch file pendingAn immune-response modulator with human clinical literature, distinct from LL-37’s direct antimicrobial activity.
UnavailableAsk about availability -
Early human evidence
Thymosin Beta-4
£62.0010 mgBatch file pendingFull-length endogenous thymosin beta-4 with broader actin biology, rather than the shorter TB-500-style material.
UnavailableAsk about availability -
Established
Tirzepatide
£79.0010 mgBatch file pendingDual incretin agonism distinguishes it from single-target semaglutide and triple-target retatrutide.
UnavailableAsk about availability